Current Cardiovascular Risk Reports

, Volume 6, Issue 5, pp 425–430 | Cite as

The Management of Carotid Stenoses in the Elderly

Elderly and Cardiovascular Disease (DE Forman and JM Gaziano)


Asymptomatic individuals with a significant carotid artery stenosis are at a higher risk of stroke. However, the optimal management strategy of elderly patients with asymptomatic carotid disease is controversial. Medical management with intensive atherosclerosis risk factor modification is the cornerstone of treatment as it decreases both the incidence of stroke and events in other vascular arterial beds (e.g., myocardial infarction). While data support invasive revascularization of carotid artery stenosis in select asymptomatic individuals, the magnitude of benefit in the elderly population beyond optimal medical treatment is less clear. This is due to a higher periprocedural/ perioperative risk of adverse events and a lower life expectancy compared to younger patients. In certain elderly patients with favorable anatomy, procedural risk, and life expectancy, carotid revascularization by endarterectomy or stenting may offer additional benefits beyond intensive medical therapy. Further clinical trials should determine whether revascularization offers benefits beyond optimal medical therapy and whether certain clinical features or non-invasive tests can select those with greater benefits.


Elderly Carotid artery stenosis Carotid endarterectomy Carotid stenting Stroke Peripheral arterial disease Atherosclerosis 


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Lammie GA, Sandercock PA, Dennis MS. Recently occluded intracranial and extracranial carotid arteries. Relevance of the unstable atherosclerotic plaque. Stroke. 1999;30(7):1319–25.PubMedCrossRefGoogle Scholar
  2. 2.
    U.S. Census Bureau, Statistical Abstract of the United States. 2012. Available from:
  3. 3.
    Lee LK, Bateman BT, Wang S, et al. Trends in the hospitalization of ischemic stroke in the United States, 1998–2007. Int J Stroke. 2012;7(3):195–201.PubMedGoogle Scholar
  4. 4.
    • Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–e220. This document provides up to date stroke statistics highlighting the continued importance and frequency of stroke in the United States. PubMedCrossRefGoogle Scholar
  5. 5.
    Silverman ME, Murray T, Lock B, Charles S, editors. The Quotable Osler. Philadelphia: American College of Physician; 2003.Google Scholar
  6. 6.
    Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35(3):776–85.PubMedCrossRefGoogle Scholar
  7. 7.
    Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13.PubMedCrossRefGoogle Scholar
  8. 8.
    • Brott TG, Halperin JL, Abbara S, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation. 2011;124(4):e54–e130. Intersocietal consensus statement with guideline recommendations for the treatment of asymptomatic carotid artery disease. PubMedCrossRefGoogle Scholar
  9. 9.
    Ogata J, Masuda J, Yutani C, Yamaguchi T. Rupture of atheromatous plaque as a cause of thrombotic occlusion of stenotic internal carotid artery. Stroke. 1990;21(12):1740–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Naylor AR. Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol. 2012;9(2):116–24.CrossRefGoogle Scholar
  11. 11.
    Hobson 2nd RW, Weiss DG, Fields WS, Goldstone J, Moore WS, Towne JB, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med. 1993;328(4):221–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273(18):1421–8.Google Scholar
  13. 13.
    Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363(9420):1491–502.PubMedCrossRefGoogle Scholar
  14. 14.
    •• Brott TG, Hobson 2nd RW, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23. The CREST Trial represents the most contemporary data comparing surgical endarterectomy and carotid artery stenting. In this study of 2502 patients, there was no difference in the primary endpoint of stroke, myocardial infarction or death between the endarterectomy and stenting groups. During the periprocedural period there was a higher risk of myocardial infarction in the surgical group and a higher risk of stroke in the stenting group. PubMedCrossRefGoogle Scholar
  15. 15.
    • Voeks JH, Howard G, Roubin GS, Malas MB, Cohen DJ, Sternbergh 3rd WC, et al. Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial. Stroke. 2011;42(12):3484–90. This paper explores data from the CREST Trial suggesting that patients over the age of 70 had a higher rate of the primary endpoint with carotid artery stenting compared to endarterectom which was driven by increased risk of stroke. PubMedCrossRefGoogle Scholar
  16. 16.
    Gray WA, Simonton CA, Verta P. Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel Meeting on the ACCULINK and ACCUNET Carotid Artery Stent System. Circulation. 2012;125(18):2256–64.PubMedCrossRefGoogle Scholar
  17. 17.
    •• Halliday A, Harrison M, Hayter E, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376(9746):1074–84. Ten year data from the landmark ACST Trial. Important findings include continued decreased stroke rates at 10 years with successful CEA for patients with asymptomatic carotid artery stenosis. However the magnitude of the benefit is reduced with improved contemporary medical therapies and these findings were not found in patients over 75 years old. PubMedCrossRefGoogle Scholar
  18. 18.
    Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009;8(5):453–63.PubMedCrossRefGoogle Scholar
  19. 19.
    Kadoglou NP, Gerasimidis T, Moumtzouoglou A, Kapelouzou A, Sailer N, Fotiadis G, et al. Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. Eur J Vasc Endovasc Surg. 2008;35(6):661–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Amarenco P, Bogousslavsky J, Callahan 3rd A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549–59.PubMedCrossRefGoogle Scholar
  21. 21.
    Kinlay S. Fire in the hole: carotid stenting versus endarterectomy. Circulation. 2011;123(22):2522–5.PubMedCrossRefGoogle Scholar
  22. 22.
    • Markus HS, King A, Shipley M, et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol. 2010;9(7):663–71. Study demonstrating improved risk stratification utilizating transcranial doppler signals to help identify which patients with asymptomatic carotid artery disease are more likely to develop a transient ischemic attack or an ipsilateral stroke. PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC (outside the USA) 2012

Authors and Affiliations

  1. 1.Cardiovascular DivisionVA Boston Healthcare System, Brigham and Women’s Hospital, and Harvard Medical SchoolBostonUSA
  2. 2.Interventional Cardiology and Vascular Medicine Section, Cardiovascular DivisionVA Boston Healthcare SystemWest RoxburyUSA
  3. 3.Brigham and Women’s Hospital, and Harvard Medical SchoolBostonUSA

Personalised recommendations